Columbia, MD—May 30, 2025—Precision Antibody, a leading provider of custom monoclonal antibody development services, is pleased to announce its attendance at the upcoming Antibody Engineering & Therapeutics Europe, taking place June 10–12, 2025, at the Congress Center Basel, Switzerland.
The event, hosted by Informa Connect, is Europe’s premier conference for professionals advancing antibody research, engineering, and development. It brings together scientific experts, biotech leaders, and solution providers to discuss breakthroughs in antibody discovery, therapeutic design, and clinical development.
“We’re excited to engage with innovators and scientists who are shaping the future of antibody engineering,” said Dr. Hayashi. “Our mission is to help researchers accelerate discovery by providing high-quality, high-specificity monoclonal antibodies that deliver reliable results, every time.”
Precision Antibody’s proven expertise in generating antibodies that work "right the first time" has made it a trusted partner for biopharma and academic researchers worldwide. Attendees at Antibody Engineering & Therapeutics Europe are invited to connect with the Precision Antibody team to explore how their antibody solutions can streamline discovery workflows and advance therapeutic development.

About Precision Antibody
Founded in 2000, Precision Antibody is a U.S.-based biotechnology company specializing in the development of high-affinity, high-specificity monoclonal antibodies. With a commitment to speed, quality, and reliability, Precision Antibody empowers researchers across academia, biotechnology, and the pharmaceutical industry to achieve scientific breakthroughs more quickly.

Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: [email protected]
Website: www.precisionantibody.com

Event Details:
Antibody Engineering & Therapeutics Europe
Dates: June 10 - 12, 2025
Venue: Congress Center, Basel, Switzerland
Event Website: https://informaconnect.com/antibody-engineering-europe/